Monitoring of heparin anticoagulation during complex aortic endovascular surgery

The paper by Dieplinger and colleagues1 in the Journal of Vascular Surgery describes the association between activated clotting time (ACT) and anti-activated factor X (anti-Xa) activity for managing anticoagulation during complex vascular surgery. The authors concluded that anti-Xa activity should be used instead of ACT. We have discussed similar concerns in our high-volume tertiary vascular surgical unit and would like to contribute our data.

Source: Journal of Vascular Surgery - March 20, 2020 Category: Surgery Authors: Tom Salih, Louisa Shovel, Christine Sathananthan, Aayushi Gupta, Anne Riddell, Ciara Donohue, Nick Schofield Tags: Letter to the Editor Source Type: research